MICHAEL BROWN: Open Payments
NPI 1215479241 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,223 in 38 payments from 19 companies in 2025. Trend: 2023 $16 · 2024 $0 · 2025 $1,223
Food & beverage: $1,223
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 11 | $212 |
| AstraZeneca Pharmaceuticals LP | 4 | $174 |
| Madrigal Pharmaceuticals | 4 | $172 |
| Intercept Pharmaceuticals, Inc. | 1 | $124 |
| INTUITIVE SURGICAL, INC. | 1 | $118 |
| Galvanize Therapeutics, Inc | 1 | $101 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| Viatris Specialty LLC | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
Products named: REZDIFFRA, Bylvay, AIRSUPRA, OCALIVA, Da Vinci Surgical System, ALIYA SYSTEM, IQIRVO, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
